The short answer

Substance lists move on schedules buyers can plan around: REACH candidate entries arrive roughly twice a year, exemptions evolve through published reviews, and thresholds tighten with notice. Tracking is a routine, not a vigil.

Key takeaways

  1. Test production-equivalent units drawn from bulk material, because golden samples prepared for the lab say nothing about what actually ships.
  2. Match the test scope to the product's materials and markets before sampling, since every omitted substance is a blind spot and every irrelevant test is wasted money.
  3. Protect the chain of custody from factory floor to laboratory door — sealed, labeled, and documented — or the report's verdict cannot be tied to the shipment.
  4. Read detection limits and units before reading verdicts: a pass without understanding the limit it passed against is an assumption, not evidence.
  5. Use accredited laboratories whose reports travel across borders, so one test program satisfies both the buyer's QA and the market's regulators.

List tracking is information triage: monitor authoritative sources on schedule, screen updates against the material file, and convert only genuine overlaps into testing or declaration work. Noise in, signal out — by procedure.

Third-party coordination matters because the factory's interests and the test's integrity pull in opposite directions. Independent sampling, independent custody, and independent lab selection are what make the final report bankable.

The buyers who spend least on testing per compliant shipment are rarely the ones who test least — they are the ones who scope precisely, sample representatively, and retest only on genuine triggers.

What moves and when

Candidate-list expansions arrive in batches, typically mid-year and year-end, adding substances of very high concern that trigger communication duties above threshold concentrations and foreshadow authorization requirements. Each batch needs screening against product materials within weeks, not quarters.

Exemption reviews reshape RoHS practice at longer intervals: lead-in-alloy allowances, cadmium-in-contact tolerances, and similar carve-outs carry expiry dates and renewal proceedings. Products designed around exemptions need calendar watches distinct from substance screening.

Threshold mechanics decide the workload: article-level versus component-level interpretation, concentration calculations per homogeneous material, and communication versus notification duties at different levels. Misreading the threshold math either panics over irrelevance or sleeps through obligations. Factory acceptance testing applies the same logic at the source: verify the product against agreed criteria before it ships rather than disputing it after it lands.[1]

How the testing run proceeds

Sampling opens the cycle and decides its value: units drawn randomly from finished or near-finished production, covering the color, material, and component variants the scope names. Factory-offered samples are declined in favor of independent draws, and the selection record notes quantities, positions, and witnesses.

Illustration: How the testing run Decorative illustration for the section "How the testing run"; visual only, carries no data.

Sealing and documentation follow immediately: tamper-evident seals, sample labels matching the booking codes, photographs of the drawn units with their packaging, and a handover record signed at the factory gate. Gaps here become dispute material later, when a failure needs tracing to a specific lot. See the inspection scope and match each checkpoint to a clause in the purchase contract.

At the laboratory, scope confirmation precedes testing — the lab verifies sample quantity, matrix suitability, and the requested standards before instruments run. Short or unsuitable samples trigger a hold notice rather than a compromised test, which is why sending spares with the first shipment saves weeks. Acceptance sampling works because the plan is agreed upfront — sample size, defect classes, and the accept-or-reject threshold leave no room for renegotiation on the factory floor.[2]

Running the update routine

  1. Monitor the source.Watch the authoritative publications on their natural rhythm — candidate batches, exemption proceedings — rather than reacting to forwarded alarms.
  2. Screen against the file.Check each new entry against current bills of materials first; most updates die at this step for most products.
  3. Query overlaps only.Ask suppliers about plausible intersections with deadlines, escalating to gap testing where declarations cannot rule substances out.
  4. Memo and file.Record the review per product family with date, entries checked, conclusion, and any actions — the memo proves diligence.

After the report: from results to action

Failures split into three commercial paths: contained substitution of the offending material with retest, lot-wide remediation where contamination spread, or rejection where the supply base cannot deliver compliance. The report's material breakdown, not its headline, chooses the path.

Illustration: After the report Decorative illustration for the section "After the report"; visual only, carries no data.

Borderline passes deserve conditions, not celebrations: narrowed supplier approval, incoming verification on the drifting material, tighter retest triggers. Treating a near-limit result as a clean bill of health wastes the early warning the money paid for.

Feed every result back to the bill of materials. Test reports that never update the material file leave the next order scoping from stale assumptions — the most common reason buyers retest irrelevancies while missing new risks.

Spare units sent with the first lab shipment prevent the most common delay: insufficient material for confirmatory runs. A handful of extra pieces costs little freight and saves a full resampling cycle when the lab queries quantity.

Homogeneous-material thinking should shape factory conversations long before testing. Suppliers who understand that each distinct material faces its own limit prepare cleaner bills of materials — and cleaner test outcomes.

Translation of material declarations deserves verification, not trust. Declarations arriving in English from multi-tier Chinese supply chains pass through hands with varying incentives; testing spot-checks the translation against reality.

Worth remembering

The lab tests what it receives; the sampling decides what that means. Every euro of testing precision is wasted when the sample was hand-picked, the custody undocumented, or the scope copied from a different product.

Sources

  1. Wikipedia: Factory acceptance test —— Overview of factory acceptance testing performed before shipment or installation.
  2. Wikipedia: Acceptance sampling —— Overview of acceptance sampling including AQL concepts used in product inspection.

Frequently asked questions

What should we do the week a candidate list grows?

Screen the new entries against current bills of materials, query suppliers only for plausible overlaps, and commission gap testing solely where declarations cannot rule substances out. Close the review with a dated memo per product family — the memo is the evidence the review happened.

How do exemptions affect our testing scope?

Active exemptions narrow required testing for covered applications; expiring ones demand redesign or re-qualification timelines. Track each relied-upon exemption's status and expiry alongside the substance scope, not in a separate forgotten file.

Who owns list tracking in a small buying team?

One named person with a twice-yearly calendar reminder, a subscription to the authoritative publication feed, and access to current material files. Tracking fails as everybody's job and succeeds as one person's routine.

Do we need to retest everything after each update?

No — test only the overlap: materials plausibly containing new entries where declarations are absent or weak. Blanket retesting after every list change is the most expensive possible substitute for a current material file.